Search for Clinical Trial Results
Adrenocortical Carcinoma - 64 Studies Found
Status | Study |
Withdrawn |
Study Name: Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients Condition: Adrenocortical Carcinoma Date: 2008-11-05 Interventions:
|
Active, not recruiting |
Study Name: Surgery and Heated Chemotherapy for Adrenocortical Carcinoma Condition:
Date: 2013-04-12 Interventions:
|
Not yet recruiting |
Study Name: Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma Condition:
Date: 2017-04-02 Interventions:
|
Active, not recruiting |
Study Name: Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma Condition:
Date: 2017-04-26 Interventions: Drug: Abiraterone Acetate Cohort 1: |
Active, not recruiting |
Study Name: Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma Condition:
Date: 2007-04-04 |
Completed |
Study Name: A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection Condition: Adrenal Cortical Carcinoma Date: 1999-11-03 Interventions: Drug: doxorubicin, vincristine, and etoposide with mitotane |
Recruiting |
Study Name: Evaluation of Side Effects of Mitotane Condition: Adrenocortical Carcinoma Date: 2007-12-04 |
Terminated |
Study Name: Possible New Therapy for Advanced Cancer Condition: Adrenocortical Carcinoma Date: 2012-09-11 Interventions: Drug: IL-13-PE IL-13-PE intravenous infusion Other N |
Recruiting |
Study Name: Efficacy of Adjuvant Mitotane Treatment (ADIUVO) Condition: Adrenocortical Carcinoma Date: 2008-10-21 Interventions: Drug: MITOTANE mitotane will be administered at a starting dose of 1.5 g/day and increased in case of go |
Recruiting |
Study Name: Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma Condition:
|